» Articles » PMID: 7601429

Effect of Immunosuppressive and Antiviral Agents on Hepatitis B Virus Replication in Vitro

Overview
Journal Hepatology
Specialty Gastroenterology
Date 1995 Jul 1
PMID 7601429
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis B virus (HBV) DNA-transfected hepatoma cells were incubated with the immunosuppressive agents prednisolone, azathioprine, and cyclosporin A (CsA) and the antiviral agents ganciclovir and foscarnet to investigate the effects of these compounds on HBV replication. Prednisolone and azathioprine increased intracellular viral DNA and RNA levels approximately twofold and fourfold, respectively. Treatment with CsA did not alter the levels of viral RNA or DNA. A combination of all three immunosuppressive agents increased the level of intracellular viral DNA eightfold, indicating an additive effect. Incubation of the cells in the presence of foscarnet decreased levels of both single-stranded and relaxed circular viral DNA, and in the presence of ganciclovir decreased the levels of relaxed circular viral DNA, predictable effects from their known mechanism of action. The stimulatory effect on viral replication induced by the combination of immunosuppressive agents was substantially inhibited by ganciclovir-foscarnet treatment. These observations could have implications for the management of recurrent HBV infection after liver transplantation.

Citing Articles

Significance of detectable hepatitis B virus DNA in liver allograft tissue in long-term follow-up of liver transplant recipients.

Mut Surmeli D, Turan I, Akay S, Erensoy S, Ersoz G, Gunsar F Hepatol Forum. 2022; 2(2):43-48.

PMID: 35783904 PMC: 9138924. DOI: 10.14744/hf.2021.2021.0003.


Role of nucleoside/nucleotide analogues and low-dose hepatitis B immune globülin in prophylaxis of hepatitis B recurrence among cadaveric liver transplant recipients.

Ajayi T, Luu H, Saberi B, Hamilton J, Konduk B, Ozseker B Turk J Gastroenterol. 2018; 29(1):61-66.

PMID: 29391309 PMC: 6322615. DOI: 10.5152/tjg.2018.17595.


Prophylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New?.

Harmanci O, Selcuk H, Haberal M J Clin Transl Hepatol. 2015; 2(4):259-65.

PMID: 26356785 PMC: 4521236. DOI: 10.14218/JCTH.2014.00023.


S-phase arrest after vincristine treatment may promote hepatitis B virus replication.

Xu L, Tu Z, Xu G, Hu J, Cai X, Zhan X World J Gastroenterol. 2015; 21(5):1498-509.

PMID: 25663769 PMC: 4316092. DOI: 10.3748/wjg.v21.i5.1498.


Strategies for the prevention of recurrent hepatitis B virus infection after liver transplantation.

Manne V, Allen R, Saab S Gastroenterol Hepatol (N Y). 2014; 10(3):175-9.

PMID: 24829544 PMC: 4014049.